共 95 条
[1]
Ambler MT(2009)The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Malar J 8 207-286
[2]
Dubowitz LM(1996) malaria Ann Trop Paediatr 16 281-279
[3]
Arunjerdja R(1990)Mefloquine in infants and young children Clin Pharmacokinet 19 264-40
[4]
Hla EP(2010)Clinical pharmacokinetics of mefloquine Am J Trop Med Hyg 82 1034-1660
[5]
Thwai KL(2006)Safety and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria Trop Med Int Health 11 1653-133
[6]
Viladpainguen J(1999)An open label randomized comparison of mefloquine-artesunat as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand J Travel Med 6 122-383
[7]
Singhasivanon P(1995) ine for malaria chemoprophylaxis 1992-1998: A review Drug Safety 12 370-1009
[8]
Luxemburger C(2009)CNS adverse events associated with antimalarial agents. Fact or fiction? J Child Neurol 24 1008-368
[9]
Nosten F(2002)Childhood mefloquine-induced mania and psychosis: a case report Ann Trop Paediatr 22 355-87
[10]
McGready R(1994)A new approach for neurological evaluation of infants in resource-poor settings Bull World Health Organ 72 83-61